CJC-1295 WITHOUT DAC+5MG IPA

CJC-1295 Without DAC (5mg) + Ipamorelin (5mg) combines two of the most extensively researched peptides used in growth hormone secretagogue studies. This advanced dual-peptide formulation is designed to investigate the natural regulation of growth hormone release through two complementary biological pathways.

CJC-1295 Without DAC is a modified Growth Hormone Releasing Hormone (GHRH) analog developed to stimulate physiological growth hormone pulses. Unlike the DAC-modified version, the “Without DAC” formulation has a shorter duration of activity, making it popular in research focused on mimicking natural pulsatile GH secretion.

Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that has been widely studied for its ability to promote growth hormone release while demonstrating minimal interaction with cortisol and prolactin pathways under experimental conditions.

Together, these peptides provide complementary mechanisms of action that make them one of the most widely researched combinations in recovery, longevity, metabolic, and performance-related peptide studies.

Key Research Areas

• Growth hormone secretion studies
• GHRH and ghrelin receptor signaling
• Recovery and regeneration research
• Sleep quality and GH pulse investigations
• Lean body composition research
• Healthy aging and longevity pathways
• Metabolic function studies
• Peptide synergy research

Product Specifications

• Peptides: CJC-1295 Without DAC + Ipamorelin
• Strength: 5mg + 5mg
• Format: Lyophilized peptide
• Grade: Research-use peptide
• Purity: High-purity laboratory standard
• Storage: Store refrigerated at 2°C–8°C before reconstitution
• Intended Use: Scientific and laboratory research only

Why Researchers Study This Combination

The combination of CJC-1295 Without DAC and Ipamorelin has become a benchmark in growth hormone research because each peptide targets a different mechanism involved in GH secretion. CJC-1295 Without DAC stimulates GHRH receptors, while Ipamorelin activates ghrelin receptors, creating a complementary signaling profile that closely reflects physiological GH release patterns.

Because of this synergistic approach, the combination is frequently investigated in studies involving recovery, muscle physiology, body composition, sleep, metabolic regulation, and healthy aging.

Important Notice

This product is intended strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. This investigational peptide formulation has not been approved for therapeutic or pharmaceutical applications. Keep out of reach of children.